Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30134% above fair value
$53.75−2.21 (-3.95%)
Close on Nov 20, 2026Market cap $1.85BP/E 36.6Yield –
Ingevity gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Ingevity's gross profit for the twelve months ending Jun 30, 2026 was $477.10M, up 1.3% year over year. For fiscal 2025 it was $461.50M, down 0.7% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $570.10M in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $461.50M | -0.7% |
| FY2024 | Dec 31, 2024 | $464.80M | +4.4% |
| FY2023 | Dec 31, 2023 | $445.00M | -21.9% |
| FY2022 | Dec 31, 2022 | $570.10M | +11.2% |
| FY2021 | Dec 31, 2021 | $512.80M | +10.2% |
| FY2020 | Dec 31, 2020 | $465.50M | -3.4% |
| FY2019 | Dec 31, 2019 | $482.00M | +15.6% |
| FY2018 | Dec 31, 2018 | $416.80M | +26.7% |
| FY2017 | Dec 31, 2017 | $329.00M | +19.9% |
| FY2016 | Dec 31, 2016 | $274.40M | -0.4% |
| FY2015 | Dec 31, 2015 | $275.40M | -13.5% |
| FY2014 | Dec 31, 2014 | $318.50M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $139.00M | +8.8% |
| Q1 FY2026 | Mar 31, 2026 | $116.40M | +4.0% |
| Q4 FY2025 | Dec 31, 2025 | $87.80M | -12.1% |
| Q3 FY2025 | Sep 30, 2025 | $133.90M | +1.7% |
| Q2 FY2025 | Jun 30, 2025 | $127.80M | +3.7% |
| Q1 FY2025 | Mar 31, 2025 | $111.90M | +12.2% |
| Q4 FY2024 | Dec 31, 2024 | $99.90M | +206.4% |
| Q3 FY2024 | Sep 30, 2024 | $131.60M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | $123.20M | -19.5% |
| Q1 FY2024 | Mar 31, 2024 | $99.70M | -23.5% |
| Q4 FY2023 | Dec 31, 2023 | $32.60M | -69.1% |
| Q3 FY2023 | Sep 30, 2023 | $129.00M | -26.8% |
| Q2 FY2023 | Jun 30, 2023 | $153.00M | +1.6% |
| Q1 FY2023 | Mar 31, 2023 | $130.40M | -5.4% |
| Q4 FY2022 | Dec 31, 2022 | $105.40M | +0.4% |
| Q3 FY2022 | Sep 30, 2022 | $176.30M | +24.3% |
| Q2 FY2022 | Jun 30, 2022 | $150.60M | +7.7% |
| Q1 FY2022 | Mar 31, 2022 | $137.80M | +9.2% |
| Q4 FY2021 | Dec 31, 2021 | $105.00M | -17.6% |
| Q3 FY2021 | Sep 30, 2021 | $141.80M | +1.6% |
| Q2 FY2021 | Jun 30, 2021 | $139.80M | +66.6% |
| Q1 FY2021 | Mar 31, 2021 | $126.20M | +10.1% |
| Q4 FY2020 | Dec 31, 2020 | $127.40M | +14.8% |
| Q3 FY2020 | Sep 30, 2020 | $139.60M | +0.1% |
| Q2 FY2020 | Jun 30, 2020 | $83.90M | -37.6% |
| Q1 FY2020 | Mar 31, 2020 | $114.60M | +18.0% |
| Q4 FY2019 | Dec 31, 2019 | $111.00M | +13.7% |
| Q3 FY2019 | Sep 30, 2019 | $139.50M | +17.6% |
| Q2 FY2019 | Jun 30, 2019 | $134.40M | +16.4% |
| Q1 FY2019 | Mar 31, 2019 | $97.10M | +14.1% |
| Q4 FY2018 | Dec 31, 2018 | $97.60M | +29.6% |
| Q3 FY2018 | Sep 30, 2018 | $118.60M | +27.3% |
| Q2 FY2018 | Jun 30, 2018 | $115.50M | +28.6% |
| Q1 FY2018 | Mar 31, 2018 | $85.10M | +20.4% |
| Q4 FY2017 | Dec 31, 2017 | $75.30M | +33.7% |
| Q3 FY2017 | Sep 30, 2017 | $93.20M | +15.9% |
| Q2 FY2017 | Jun 30, 2017 | $89.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $70.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $56.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $80.40M | – |
See a number that looks wrong?